Active Not Recruiting PHASE4 INTERVENTIONAL 2-arm NCT03201848

The Efficacy and Safety of Huaiqihuang Granule in Children With Chronic Primary Immune Thrombocytopenia (ITP)

A Multisite, Randomized, Double-Blind, Placebo-Controlled, and Parallel Study to Evaluate the Efficacy and Safety of Huaiqihuang Granule in Children With Chronic Primary Immune Thrombocytopenia (Qi Yin Deficiency)

Sponsor: Huazhong University of Science and Technology

Conditions Immune Thrombocytopenia

Interventions Huaiqihuang Granule Placebo

Updated 15 times since 2017 Last updated: Jun 2, 2024 Started: Nov 16, 2017 Primary completion: Oct 14, 2023 Completion: Jun 30, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03201848, this PHASE4 trial focuses on Immune Thrombocytopenia and remains ongoing. Sponsored by Huazhong University of Science and Technology, it has been updated 15 times since 2017, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

15 versions recorded

Sep 2024 — Present [monthly]

Active Not Recruiting PHASE4
Jul 2024 — Sep 2024 [monthly]

Active Not Recruiting PHASE4
Jun 2024 — Jul 2024 [monthly]

Active Not Recruiting PHASE4
Jan 2024 — Jun 2024 [monthly]

Active Not Recruiting PHASE4
Nov 2023 — Jan 2024 [monthly]

Active Not Recruiting PHASE4

Status: Recruiting → Active Not Recruiting

▶ Show 10 earlier versions

Jun 2023 — Nov 2023 [monthly]

Recruiting PHASE4
Jan 2023 — Jun 2023 [monthly]

Recruiting PHASE4
Jul 2022 — Jan 2023 [monthly]

Recruiting PHASE4
Mar 2022 — Jul 2022 [monthly]

Recruiting PHASE4
Sep 2021 — Mar 2022 [monthly]

Recruiting PHASE4
Jan 2021 — Sep 2021 [monthly]

Recruiting PHASE4
Nov 2019 — Jan 2021 [monthly]

Recruiting PHASE4
Jun 2018 — Nov 2019 [monthly]

Recruiting PHASE4
Aug 2017 — Jun 2018 [monthly]

Recruiting PHASE4

Status: Not Yet Recruiting → Recruiting
Jul 2017 — Aug 2017 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Huazhong University of Science and Technology
Qidong Gaitianli Medicines Co., Ltd

Data source: Qidong Gaitianli Medicines Co., Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Beijing, China , Guangzhou, China , Luzhou, China , Nanchang, China , Nanjing, China , Qingdao, China , Shanghai, China , Suzhou, China , Wuhan, China , Zhengzhou, China and 1 more location